This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Supernus Pharmaceuticals Inc (SUPN)

NASDAQ: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash and Equivalents 36.40M 32.98M 40.30M 48.54M
Receivables 17.27M 5.54M 675.00K 128.00K
Inventories 13.44M 7.15M 1.15M 0.00
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 108.89M 97.16M 91.74M 49.40M
Property, Plant & Equipment, Gross 8.74M 8.14M 6.50M 5.75M
Accumulated Depreciation & Depletion 6.29M 5.59M 5.08M 4.44M
Property, Plant & Equipment, Net 2.45M 2.55M 1.42M 1.31M
Intangibles 5.43M 1.16M 683.00K 912.00K
Other Non-Current Assets 20.73M 10.12M 144.00K 2.11M
Total Non-Current Assets 28.62M 13.83M 2.25M 4.33M
Liabilities & Shareholder Equity
Total Assets 137.51M 111.00M 93.99M 53.73M
Accounts Payable 1.86M 3.14M 10.67M 10.08M
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 0.00 0.00 0.00 0.00
Total Current Liabilities 27.49M 26.40M 22.98M 18.77M
Long Term Debt 26.95M 34.39M 11.09M 22.71M
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 11.71M 16.74M 2.35M 2.81M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 38.66M 51.13M 13.44M 25.52M
Total Liabilities 66.15M 77.53M 36.42M 44.29M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 71.35M 33.46M 57.57M 9.44M
Common Par 43.00K 40.00K 31.00K 14.00K
Additional Paid In Capital 230.12M 211.95M 143.85M 49.40M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -158.66M -178.53M -86.26M -39.97M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments -154.00K 0.00 -57.00K 1.00K
Total Capitalization 98.30M 67.86M 68.66M 32.15M
Total Equity 71.35M 33.46M 57.57M 9.44M
Total Liabilities & Stock Equity 137.51M 111.00M 93.99M 53.73M
Total Common Shares Outstanding 42.97M 39.98M 30.62M 23.91M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 42.26M 31.85M 17.44M 13.86M
Diluted Weighted Shares Outstanding 50.58M 31.85M 17.44M 13.86M
Number of Employees 309 235 193 71
Number of Part-Time Employees 0 0 0 0

SUPN Supernus Pharmaceuticals Inc

Chart of SUPN

Analysts Ratings for SUPN

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 5 5 5 3
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

Brokerage Partners

SUPN Chatter

Select the service that is right for you!

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs